SCHEMBL25825689

SCHEMBL25825689

O=C(Nc1ccc(Nc2ccccc2)cc1)Oc1ccc(Nc2ccncc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
GAA P10253 3/20 0.60
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
MAPT P10636 3/20 0.56
RAB9A P51151 1/20 0.56
TAAR1 Q96RJ0 1/20 0.56
HSP90AA1 P07900 1/20 0.55
RAD51 Q06609 1/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
KDM4E B2RXH2 1/20 0.52
THRB P10828 1/20 0.52
GFER P55789 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
POLB P06746 1/20 0.52
PORCN Q9H237 1/20 0.52
CASP3 P42574 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999489 0.94 MAPT (0.53) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL9480270 0.91 ALDH1A1 (0.72) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL589501 0.89 ALDH1A1 (0.65) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL5177511 0.89 ALDH1A1 (0.65) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL24003957 0.88 MAPT (0.49) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL9480551 0.87 ALDH1A1 (0.72) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL15140688 0.83 PORCN (0.64) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL9480171 0.83 ALDH1A1 (0.67) ALDH1A1GAAHTTSMN1; SMN2MAPT
SCHEMBL25825682 0.80 TAAR1 (0.85) GAAHTTSMN1; SMN2MAPTRAB9A
Phenyl Phenylcarbamate SCHEMBL272994 0.80 ALDH1A1 (0.76) ALDH1A1GAAHTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR ALDH1A1 4541/4885GAA 819/4885HTT 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.